SCHEMBL10036041

SCHEMBL10036041

CC[n+]1c(/C=C/C=C/c2ccc(N(C)C)cc2)ccc2ccccc21

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.83
MEN1 O00255 9/20 0.83
RAB9A P51151 9/20 0.83
HTT P42858 8/20 0.83
NPSR1 Q6W5P4 6/20 0.83
POLB P06746 6/20 0.83
L3MBTL1 Q9Y468 5/20 0.83
BLM P54132 4/20 0.83
SMN1; SMN2 Q16637 4/20 0.83
LMNA P02545 4/20 0.83
ALDH1A1 P00352 4/20 0.83
PPARG P37231 3/20 0.83
NCOA2 Q15596 3/20 0.83
NCOA1 Q15788 3/20 0.83
APP P05067 3/20 0.58
NPC1 O15118 6/20 0.57
MAPT P10636 6/20 0.57
THRB P10828 5/20 0.57
MAPK1 P28482 5/20 0.57
PKM P14618 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31018271 0.92 KMT2A (0.97) KMT2AMEN1RAB9AHTTNPSR1
SCHEMBL5676065 0.92 KMT2A (0.97) KMT2AMEN1RAB9AHTTNPSR1
SCHEMBL5676060 0.92 KMT2A (0.97) KMT2AMEN1RAB9AHTTNPSR1
Iodide SCHEMBL29473159 0.91 KMT2A (1.00) KMT2AMEN1RAB9AHTTNPSR1
Iodide SCHEMBL124471 0.91 KMT2A (1.00) KMT2AMEN1RAB9AHTTNPSR1
Hydrochloric Acid SCHEMBL11551422 0.91 KMT2A (0.95) KMT2AMEN1RAB9AHTTNPSR1
Iodide SCHEMBL124472 0.91 KMT2A (1.00) KMT2AMEN1RAB9AHTTNPSR1
Perchlorate SCHEMBL4877794 0.88 KMT2A (0.88) KMT2AMEN1RAB9AHTTNPSR1
Perchlorate SCHEMBL4877802 0.88 KMT2A (0.88) KMT2AMEN1RAB9AHTTNPSR1
SCHEMBL2948028 0.87 KMT2A (0.67) KMT2AMEN1RAB9AHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035187-A1 ANTI-NEURODEGENERATIVE DISEASE AGENT KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035187-A1 ANTI-NEURODEGENERATIVE DISEASE AGENT SNCA, PSEN1, CDR2 KMT2A 2624/4885MEN1 2218/4885RAB9A 1423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.